Kohjin Bio Co., Ltd. (TYO:177A)
Japan · Delayed Price · Currency is JPY 826.00
-10.00 (-1.20%)
Sep 16, 2026, 3:30 PM JST
Kohjin Bio Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 4,273 | 6,185 | 8,945 | - | - | - | |
Market Cap Growth | -46.10% | -30.86% | - | - | - | - |
Enterprise Value | 3,729 | 5,829 | 7,841 | - | - | - |
Last Close Price | 836.00 | 1210.00 | 1735.36 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.39 | 24.64 | 11.27 | - | - | - |
Forward PE | - | 13.32 | 13.32 | - | - | - |
PS Ratio | 0.91 | 1.25 | 1.72 | - | - | - |
PB Ratio | 0.73 | 1.04 | 1.55 | - | - | - |
P/TBV Ratio | 0.73 | 1.04 | 1.56 | - | - | - |
P/FCF Ratio | - | - | 168.78 | - | - | - |
P/OCF Ratio | 6.12 | 8.86 | 9.78 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.79 | 1.18 | 1.51 | - | - | - |
EV/EBITDA Ratio | 6.12 | 7.90 | 5.80 | - | - | - |
EV/EBIT Ratio | 18.28 | 17.04 | 7.91 | - | - | - |
EV/FCF Ratio | - | - | 147.95 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.31 | 0.37 | 0.41 | 0.74 | 0.70 | 1.00 |
Debt / EBITDA Ratio | 3.27 | 2.97 | 1.77 | 2.76 | - | - |
Debt / FCF Ratio | - | - | 45.02 | 9.46 | - | - |
Net Debt / Equity Ratio | -0.09 | -0.05 | -0.13 | 0.22 | 0.21 | 0.22 |
Net Debt / EBITDA Ratio | -0.97 | -0.40 | -0.56 | 0.83 | - | - |
Net Debt / FCF Ratio | - | 1.09 | -14.40 | 2.85 | - | - |
Asset Turnover | 0.52 | 0.55 | 0.67 | 0.75 | 0.81 | - |
Inventory Turnover | 3.40 | 3.52 | 3.64 | 3.24 | 2.83 | - |
Quick Ratio | 1.26 | 1.34 | 1.67 | 1.11 | 0.76 | 1.31 |
Current Ratio | 1.77 | 1.80 | 2.04 | 1.42 | 1.15 | 1.56 |
Return on Equity (ROE) | 2.21% | 4.28% | 17.41% | 12.08% | 31.68% | - |
Return on Assets (ROA) | 1.09% | 2.38% | 7.91% | 5.87% | 13.51% | - |
Return on Invested Capital (ROIC) | 2.03% | 4.85% | 17.05% | 9.35% | 26.58% | 22.48% |
Return on Capital Employed (ROCE) | 2.40% | 5.20% | 15.10% | 14.20% | 40.70% | 28.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.00% | 4.06% | 8.88% | - | - | - |
FCF Yield | -6.37% | -4.40% | 0.59% | - | - | - |
Dividend Yield | 1.18% | 0.83% | 1.38% | - | - | - |
Payout Ratio | - | 48.61% | 7.31% | 20.57% | - | - |
Buyback Yield / Dilution | 0.00% | -1.34% | -21.11% | - | -22.96% | - |
Total Shareholder Return | 1.19% | -0.51% | -19.72% | - | -22.96% | - |